Raymond A. Firestone

5.5k total citations
101 papers, 4.4k citations indexed

About

Raymond A. Firestone is a scholar working on Organic Chemistry, Molecular Biology and Oncology. According to data from OpenAlex, Raymond A. Firestone has authored 101 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Organic Chemistry, 35 papers in Molecular Biology and 23 papers in Oncology. Recurrent topics in Raymond A. Firestone's work include Peptidase Inhibition and Analysis (14 papers), Synthesis of β-Lactam Compounds (10 papers) and Various Chemistry Research Topics (10 papers). Raymond A. Firestone is often cited by papers focused on Peptidase Inhibition and Analysis (14 papers), Synthesis of β-Lactam Compounds (10 papers) and Various Chemistry Research Topics (10 papers). Raymond A. Firestone collaborates with scholars based in United States, Germany and China. Raymond A. Firestone's co-authors include Gene M. Dubowchik, Pamela A. Trail, Shirley J. Lasch, David Willner, Sandra J. Hofstead, Judith M. Pisano, B. G. CHRISTENSEN, Jay O. Knipe, Kathleen Mosure and John Lenard and has published in prestigious journals such as Nature, Science and Journal of the American Chemical Society.

In The Last Decade

Raymond A. Firestone

100 papers receiving 4.1k citations

Peers

Countries citing papers authored by Raymond A. Firestone

Since Specialization

Citations

This map shows the geographic impact of Raymond A. Firestone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raymond A. Firestone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raymond A. Firestone more than expected).

Fields of papers citing papers by Raymond A. Firestone

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raymond A. Firestone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raymond A. Firestone. The network helps show where Raymond A. Firestone may publish in the future.

Co-authorship network of co-authors of Raymond A. Firestone

This figure shows the co-authorship network connecting the top 25 collaborators of Raymond A. Firestone. A scholar is included among the top collaborators of Raymond A. Firestone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raymond A. Firestone. Raymond A. Firestone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Anticancer effects of Ac-Phe-Lys-PABC-doxorubicin via mitochondria-centered apoptosis involving reactive oxidative stress and the ERK1/2 signaling pathway in MGC-803 cells 2013 ·Oncology Reports ·(unknown), (unknown), Raymond A. Firestone, Yaping Hong, Yan Li	10
2	Targeting therapy of hepatocellular carcinoma with doxorubicin prodrug PDOX increases anti-metastatic effect and reduces toxicity: a preclinical study 2013 ·Journal of Translational Medicine ·Qun Wang, (unknown), Jingping Yuan, (unknown), Jue Zhang, Li Tang, Shaoping Liu, (unknown), Raymond A. Firestone, (unknown)	27
3	Cathepsin B cleavable novel prodrug Ac‐Phe‐Lys‐PABC‐ADM enhances efficacy at reduced toxicity in treating gastric cancer peritoneal carcinomatosis 2011 ·Cancer ·Li‐Hua Shao, Shaoping Liu, (unknown), Zhang Yan-hua, Chun‐Wei Peng, (unknown), Xiong Liu, Xiuli Liu, Yaping Hong, Raymond A. Firestone, Yan Li	50
4	Monoclonal antibody mediated intracellular targeting of tallysomycin S10b 2004 ·Bioorganic & Medicinal Chemistry Letters ·Michael Walker, Dalton King, R. A. Dalterio, Pamela A. Trail, Raymond A. Firestone, Gene M. Dubowchik	14
5	The design of potent hydrazones and disulfides as cathepsin S inhibitors 2003 ·Bioorganic & Medicinal Chemistry ·Charles L. Cywin, Raymond A. Firestone, Daniel W. McNeil, Christine A. Grygon, (unknown), Della White, (unknown), Jerry L. Hopkins, Walter Davidson, Mark E. Labadia, (unknown), Maurice M. Morelock, Jeffrey D. Peterson, Ernest Raymond, Maryanne L. Brown, Denice M. Spero	25
6	BR96 conjugates of highly potent anthracyclines 2003 ·Bioorganic & Medicinal Chemistry Letters ·Dalton King, (unknown), (unknown), (unknown), Raymond A. Firestone, Shirley J. Lasch, Pamela A. Trail	16
7	Synthesis of an immunoconjugate of camptothecin 2002 ·Bioorganic & Medicinal Chemistry Letters ·Michael Walker, Gene M. Dubowchik, Sandra J. Hofstead, Pamela A. Trail, Raymond A. Firestone	33
8	Doxorubicin immunoconjugates containing bivalent, lysosomally-Cleavable dipeptide linkages 2002 ·Bioorganic & Medicinal Chemistry Letters ·Gene M. Dubowchik, (unknown), Harold Mastalerz, Michael Walker, Raymond A. Firestone, Dalton King, Sandra J. Hofstead, David Willner, Shirley J. Lasch, Pamela A. Trail	30
9	Induction of cell death by the lysosomotropic detergent MSDH 2000 ·FEBS Letters ·Wei Li, Xi Yuan, (unknown), Helge Dalen, Gene M. Dubowchik, Raymond A. Firestone, Ulf T. Brunk	209
10	Cathepsin B-sensitive dipeptide prodrugs. 1. A model study of structural requirements for efficient release of doxorubicin 1998 ·Bioorganic & Medicinal Chemistry Letters ·Gene M. Dubowchik, Raymond A. Firestone	133
11	Cathepsin B-sensitive dipeptide prodrugs. 2. Models of anticancer drugs paclitaxel (Taxol®), mitomycin C and doxorubicin 1998 ·Bioorganic & Medicinal Chemistry Letters ·Gene M. Dubowchik, Kathleen Mosure, Jay O. Knipe, Raymond A. Firestone	88
12	Improved Cytotoxicity of Antitumor Compounds Deliverable by the LDL Pathway 1995 ·Bioconjugate Chemistry ·Gene M. Dubowchik, Raymond A. Firestone	16
13	The in vitro effects of three lysosomotropic detergents against three human tumor cell lines 1995 ·Bioorganic & Medicinal Chemistry Letters ·Gene M. Dubowchik, Susan L. Gawlak, Raymond A. Firestone	15
14	Low-Density Lipoprotein as a Vehicle for Targeting Antitumor Compounds to Cancer Cells 1994 ·Bioconjugate Chemistry ·Raymond A. Firestone	189
15	Reversal of doxorubicin resistance and catalytic neutralization of lysosomes by a lipophilic imidazole 1994 ·Biochimica et Biophysica Acta (BBA) - Biomembranes ·Gene M. Dubowchik, (unknown), (unknown), Raymond A. Firestone	16
16	Cure of Xenografted Human Carcinomas by BR96-Doxorubicin Immunoconjugates 1993 ·Science ·Pamela A. Trail, David Willner, Shirley J. Lasch, Arris J. Henderson, Sandra J. Hofstead, Anna Maria Casazza, Raymond A. Firestone, Ingegerd Hellström, K E Hellström	414
17	Effects of lysosomotropic detergents on the human malarial parasite plasmodium falciparum in in vitro culture 1989 ·Biochemical Pharmacology ·Z. Ioav Cabantchik, (unknown), Raymond A. Firestone, Miriam Krugliak, (unknown), H. Ginsburg	10
18	Cephalosporin antibiotics can be modified to inhibit human leukocyte elastase 1986 ·Nature ·James B. Doherty, Bonnie M. Ashe, Lawrence W. Argenbright, Peter L. Barker, Robert J. Bonney, Gilbert O. Chandler, Mary Ellen Dahlgren, Conrad P. Dorn, Paul E. Finke, Raymond A. Firestone, Daniel S. Fletcher, William K. Hagmann, Richard A. Mumford, Laura O’Grady, Alan L. Maycock, Judith M. Pisano, Shrenik K. Shah, Kevan R. Thompson, Morris Zimmerman	134
19	Vibrational activation. 3. Effect of solvent density on the rate of a Diels-Alder reaction. Density as an index of porosity 1983 ·The Journal of Organic Chemistry ·Raymond A. Firestone, (unknown)	8
20	Mechanism-based enzyme inactivation using an allyl sulfoxide-allyl sulfenate ester rearrangement 1980 ·Journal of the American Chemical Society ·Michael Johnston, Ronald T. Raines, Christopher T. Walsh, Raymond A. Firestone	22

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact